Risk Minimization Activities of Centrally Authorized Products in the EU-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Risk Minimization Activities of Centrally Authorized Products in the EU

Published:2012-04 Issue:4 Volume:35 Page:299-314
ISSN:0114-5916
Container-title:Drug Safety
language:en
Short-container-title:Drug Safety

Author:

Zomerdijk Inge M.,Sayed-Tabatabaei Fakhredin A.,Trifirò Gianluca,Blackburn Stella C.F.,Sturkenboom Miriam C.J.M.,Straus Sabine M.J.M.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,Toxicology

Reference21 articles.

1. Balancing early market access to new drugs with the need for benefit/risk data: a mounting dilemma

2. Benefits and Risks of Drug Treatments

3. The Food and Drug Administration Amendments Act of 2007: Drug safety and health-system pharmacy implications

4. White paper on designing a risk evaluation and mitigation strategies (REMS) system to optimize the balance of patient access, medication safety, and impact on the health care system

5. Risk evaluation and mitigation strategies: Impact on patients, health care providers, and health systems

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Evolution of Drug Regulatory Sciences in the Netherlands: More than a Country Report;Clinical Pharmacology & Therapeutics;2024-04-28

2. Duration of Effectiveness Evaluation of Additional Risk Minimisation Measures for Centrally Authorised Medicinal Products in the EU Between 2012 and 2021;Drug Safety;2023-09-02

3. Patient Preferences for Rituximab Additional Risk Minimization Measures;Journal of Patient Safety;2022-01-28

4. Regulatory experience of handling Risk Management Plans (RMPs) for medicinal products in the EU;Expert Opinion on Drug Safety;2021-04-22

5. Pharmacists’ perception of educational material to improve patient safety;Medicine;2021-03-19

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3